InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Friday, 09/28/2018 11:58:00 AM

Friday, September 28, 2018 11:58:00 AM

Post# of 1435
Dr. Sharman on the Phase III Results of the GENUINE Study in CLL from last year around June 2017 video clip. Tell me $TGTX doesn't have a good science for CLL !!!!!!!!!!!!

Jeff Sharman, MD, medical director, Hematology Research, The US Oncology, discusses the phase III findings of the GENUINE study, the combination of ublituximab (TG-1101) and ibrutinib (Imbruvica) for patients with previously treated high-risk chronic lymphocytic leukemia (CLL).


Click on the insert-text-here
insert-text-here

Or this hyperlink below:
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TGTX News